ProvexisCHIX:PXSL Days Inventory is 115.12 as of Sep. 2025, which is 59% below its 10-year median of 283.89. The stock has 1 warning sign investors should review. Among 916 Drug Manufacturers companies, Provexis ranks better than 74.78% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Provexis's Average Total Inventories for the
six
months ended in Sep. 2025 was £0.12 Mil. Provexis's Cost of Goods Sold for the
six
months ended in Sep. 2025 was £0.20 Mil.
Hence, Provexis's Days Inventory for the
six
months ended in Sep. 2025 was 115.12.
The historical rank and industry rank for Provexis's Days Inventory or its related term are showing as below:
CHIX:PXSl'
s Days Inventory Range Over the Past 10 Years
Min: 81.51 Med: 283.89 Max: 1168
Current: 109.83
During the past 13 years, Provexis's highest Days Inventory was 1168.00. The lowest was 81.51. And the median was 283.89.
CHIX:PXSl's Days Inventory is ranked better than 74.78% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs CHIX:PXSl: 109.83
Provexis's Days Inventory
increased
from Sep. 2024 (51.68) to Sep. 2025 (115.12).
It might indicate that Provexis's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Provexis's Inventory Turnover for the
six
months ended in Sep. 2025 was 1.59.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Provexis's Inventory-to-Revenue for the
six
months ended in Sep. 2025 was 0.34.
Provexis (CHIX:PXSl) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Provexis's Inventory Turnover for the
six
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Provexis's Inventory to Revenue for the
six
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Provexis Days Inventory Related Terms
Provexis Days Inventory Historical Data
* Premium members only.
The historical data trend for Provexis's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:PXSL vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Provexis's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Provexis Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Provexis's Days Inventory distribution charts can be found below:
* The bar in red indicates where Provexis's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Provexis (CHIX:PXSL) has a Days Inventory of 115.12 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Provexis and its competitors. This is 59% below median its historical median of 283.89. Over the past decade, Provexis' Days Inventory has ranged from 81.51 to 1,168.00. According to the industry distribution chart, Provexis ranks #231 out of 916 companies in the Drug Manufacturers industry, placing it in the top 25.2%.
Is Provexis' Days Inventory too high?
Provexis' current Days Inventory of 115.12 is 59% below median its 10-year median of 283.89. Over the past 10 years, this metric has ranged from a low of 81.51 to a high of 1,168.00. The Drug Manufacturers industry median Days Inventory is 164.43. Provexis' value of 115.12 is 30% below this industry median. Based on the distribution chart, Provexis ranks #231 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Provexis' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Provexis ranks #231 out of 916 companies for Days Inventory. This puts Provexis in the upper half of its industry. The industry median Days Inventory is 164.43. Provexis' value of 115.12 is 30% below this benchmark. Historically, Provexis' own Days Inventory has ranged from 81.51 to 1,168.00 over the past decade. While the company's 10-year median is 283.89 vs. the industry median of 164.43, Provexis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Provexis's current Days Inventory of 115.12 is 30% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Provexis and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Provexis's current Days Inventory is 115.12, which is 59% below median its own 10-year median of 283.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Provexis stock overvalued right now?
Provexis (CHIX:PXSL) has a current Days Inventory of 115.12. The current Days Inventory is 115.12, which is 59% below median its 10-year median of 283.89 and 30% below the Drug Manufacturers industry median of 164.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Provexis (CHIX:PXSL), the current Days Inventory is 115.12 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Provexis PLC is engaged in developing, licensing and selling the proprietary, scientific Fruitflow heart-health functional food ingredient for the global functional food sector. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:PXSL has been successfully added to your 